Abstract
This study investigates governance models that address innovative and ethical academic scientists and organizations. It bases on management and governance theory of knowledge-intensive organizations (KIOs) that originates in research streams of knowledge-intensive firms and professional service firms. The focus is on the basic science stage of translational science that applies discoveries to humans. Despite the overall progress of understanding disease mechanisms, there are several understudied fields in biomedical sciences. Previous literature ascribes the biased agenda to the involvement of practical interests. Though there are undoubtedly such external forces, several institutional and organizational constraints are also contributing to biases. Examples include neurobiological aspects of translational pain science. This study investigates contributing factors and governance models by seeking corresponding parts between self-regulation of sciences, agency-based governance, and stakeholder theories.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Adams, M. D., Kelley, J. M., Gocayne, J. D., Dubnick, M., Polymeropoulos, M. H., Xiao, H., … Venter, C. (1991). Complementary DNA sequencing: Expressed sequence tags and human genome project. Science, 252, 1651–1656.
Alcacer, J., & Chung, W. (2007). Location strategies and knowledge spillovers. Management Science, 53(5), 760–776.
Aldrich, H., & Herker, D. (1977). Boundary spanning roles and organization structure. Academy of Management Review, 2(2), 217–230.
Alvarez, S. A., Barney, J., & Anderson, P. (2013). Forming and exploiting opportunities: The implications of discovery and creation processes for entrepreneurial and organizational research. Organization Science, 2, 301–317.
Anand, N., Gardner, K., & Morris, T. (2007). Knowledge-based innovation: Emergence and embedding of new practice areas in managing consulting firms. The Academy of Management Journal, 50(2), 406–428.
Anderson, M. S., Ronning, E. A., De Vries, R., & Martinson, B. C. (2010). Extending the Mertonian norms: Scientists’ subscription to norms of research. The Journal of Higher Education, 81(3), 366–393.
Argandona, A. (1998). Stakeholder theory and the common good. Journal of Business Ethics, 17, 1093–1102.
Armour, J., Hansmann, H., & Kraaman, R. (2017). Agency problems and legal strategies. In R. Kraaman, J. Armour, P. Davies, L. Enriques, H. Hansmann, G. Hertig, … E. Rock (Eds.), The anatomy of corporate law: A comparative and functional approach. Oxford University Press-Oxford Scholarship Online. https://doi.org/10.1093/acprof:oso/9780198739630.001.0001.
Arora, A., Belenzon, S., & Patacconi, A. (2015). Killing the golden goose? The decline of science in corporate R&D (NBER Working Paper 20902). Available at http://www.nber.org/papers/w20902.
Attas, D. (2004). A moral stakeholder theory of the firm. Ethics and Economics, 2(2), 1–8.
Azoulay, P., Zivin, J. S. G., & Manso, G. (2011). Incentives and creativity: Evidence from the academic life sciences. RAND Journal of Economics, 42(3), 527–554.
Barker, S. F. (1992). What is a profession? Professional Ethics: A Multidisciplinary Journal, 1(1–2), 73–99.
Basu, S., Wadhwa A., & Kotha, S. (2016). Corporate venture capital: Important themes and future directions. In S. A. Zahra, D. O. Neubaum, & J. C. Hayton (Eds.), Handbook of research on corporate entrepreneurship (pp. 203–234). Cheltenham and Northampton: Edward Elgar Publishing.
Bettencourt, L. A., Ostrom, A. L., Brown, S. W., & Roundtree, R. I. (2002). Client co-production in knowledge-intensive business services. California Management Review, 44(4), 100–128.
Bikard, M., Murray, F. E., & Gans J. (2013). Exploring tradeoffs in the organization of scientific work: Collaboration and scientific reward (NBER Working Paper No. 18958).
Burgers, H., & Vrande, V. V. (2016). Who is the corporate entrepreneur: Insights from opportunity discovery and creation theory. In S. A. Zahra, D. O. Neubaum, & J. C. Hayton (Eds.), Handbook of research on corporate entrepreneurship (pp. 64–86). Cheltenham and Northampton: Edward Elgar Publishing.
Buse, K., & Walt, G. (2002). The world health organization and global public-private health partnerships: In search of ‘good’ global health governance. In M. R. Reich (Ed.), Public-private partnerships for public health (pp. 169–195). Cambridge, US: Harvard Center for Population and Development Studies.
Carpenter, D. (2014). Detecting and measuring capture. In D. Carpenter & D. A. Moss (Eds.), Preventing Regulatory Capture: Special Interest Influence and How to Limit It (pp. 57–68). New York: Cambridge University Press.
Carpenter, D., & Moss, D. A. (Eds.). (2014a). Preventing regulatory capture: Special interest influence and how to limit it. New York: Cambridge University Press.
Carpenter, D., & Moss, D. A. (2014b). Introduction. In D. Carpenter & D. A. Moss (Eds.), Preventing regulatory capture: Special interest influence and how to limit it (pp. 1–24). New York: Cambridge University Press.
Cayabyab, M. J., Macovei, L., & Campos-Nelo, A. (2012). Current and novel approaches to vaccine development against tuberculosis. Front Cell Infect Microbiol, 2, 154.
Cheng, S. K., & Dilts, D. M. (2013). Building expertise in translational processes through partnerships with schools of business. In B. Alving, K. Dai, & S. H. H. Chan (Eds.), Translational medicine—What, why and how; An international perspective (Translational Research Biomedicine 3) (pp. 74–81). Basel: Kager.
Child, J., & McGrath, R. G. (2001). Organizations unfettered: Organizational form in an information-intensive economy. Academy of Management Journal, 44, 1135–1148.
Choi, C., & Millar, C. (2005). Knowledge entanglement. Hampshire and New York: Palgrave Macmillan.
Choi, C. J., Hilton, B., & Millar, C. (2004). Emerging business systems. Hampshire and New York: Palgrave Macmillan.
Christensen, T. (2011). University governance reforms: Potential problems of more autonomy? Higher Education, 62, 503–517.
Contopoulos-Ioannidis, D. G., Ntzani, E. E., & Ioannidis, J. P. (2003). Translation of highly promising basic science research into clinical applications. The American Journal of Medicine, 114(6), 477–484.
Contreras, J. L. (2011). Bermuda’s legacy: Policy, patents, and the design of the genome commons. Minnesota Journal of Law, Science & Technology, 12(1), 61–125.
Czamitzki, D., Glänzel, W., & Hussinger, K. (2008). Heterogeneity of patenting activity and its implications for scientific research. Research Policy, 38(1), 26–34.
Department of Energy & National Institute of Health (DOE & NIH). (1992). The guidelines on rapid sharing of data and material produced, Washington, D.C. Human Genome News, 4(5) January 1993. Retrieved from https://www.genome.gov/edkit/pdfs/1992b.pdf.
Disis, M. L., Tarczy-Hornoch, P., & Ramsey, B. W. (2013). Clinical research with innovative services and informatics tools. In B. Alving, K. Dai, & S. H. H. Chan (Eds.), Translational Medicine—What, Why and How: An International Perspective (Translational Research in Biomedicine, 3) (pp. 89–97). Basel: Karger.
Etzkowitz, H., & Leydoesdorff, L. (2000). The dynamics of innovation: From national system and “mode 2” to a triple helix of university-industry-government relations. Research Policy, 29, 109–123.
Etzkowitz, H., & Webster, A. (1995). Science as intellectual property. In S. Jasanoff, G. Markle, J. Petersen, & T. Pinch (Eds.), Handbook of Science and Technology Studies (pp. 480–505). Thousand Oaks: Sage.
European Commission. (2012). Knowledge-intensive (business) service in Europe. Luxembourg: Publications Office of the European Union.
Evan, W. M., & Freeman, R. E. (1988). A stakeholder theory of the modern cooperation: Kantian capitalism. In T. L. Beauchamp & N. E. Bowie (Eds.), Ethical theory and business (3rd ed.) (pp. 97–106). Englewood Cliff: Prentice Hall.
Fang, F. C., Stern, R. G., & Casadevall, A. (2012). Misconduct account for the majority of retracted publications. Proceedings of the National Academy of Sciences (PNAS), 42(109), 17028–17033. Corrections: 2013. PNAS, 110(3), 1137.
Fleming, L., & Sorenson, O. (2004). Science as a map in technological search. Strategic Management, 25(8–9), 909–928.
Fort, T. L. (2001). Ethics and governance: Business as mediating institution. New York: Oxford University Press.
Freeman, R. E. (1984). Strategic management: Stakeholder approach. Boston: Pitman.
Ghobadian, A., Gallear, D., Viney, H., & O’Regan, N. (2004). Future of the public-private partnership. In A. Ghobadian, D. Gallear, N. O’Regan, & H. Viney (Eds.), Public-private partnerships: Policy and experience (pp. 271–302). Hampshire and New York: Palgrave Macmillan.
Gibbons, M. (1999). Science’s new social contract with society. Nature, 402(C81), 11–17.
Goleman, D. (2004). What makes a leader? Harvard Business Review, 82(1), 82–91.
Gottweis, H., Salter, B., & Waldby, C. (2009). The global politics of human embryonic stem cell science: Regenerative medicine in transition. Houndmills: Palgrave Macmillan.
Greenwood, R. (2007). Redefining professionalism? The impact of management change. In L. Empson (Ed.), Managing the modern law firm: New challenges and new perspectives (pp. 186–195). Oxford: Oxford University Press.
Greenwood, R., & Empson, L. (2003). The professional partnership: Relic or exemplary form of governance? Organization Studies, 24, 909–933.
Gunz, H., Gunz, S., & Dinovitzer, R. (2015). Professional ethics: Origins, applications, and developments. In B. Hinings, D. Muzio, J. Broschak, & L. Empson (Eds.), The Oxford handbook of professional service firms (pp. 113–134). Oxford: Oxford University Press.
Hannah, S. T., Avolio, B. J., & May, D. R. (2011). Moral maturation and moral conation: A capacity approach to explaining moral thought and action. Academy of Management Review, 36(4), 663–685.
Den Hertog, P. (2000). Knowledge-intensive business services as co-production of innovation. International Journal of Innovation Management, 4(4), 491–528.
Hinings, B., Muzio, D., Broschak, J., & Empson, L. (Eds.). (2015a). The Oxford handbook of professional service firms. Oxford: Oxford University Press.
Hinings B., Muzio, D., Broschak, J., & Empson, L. (2015b). Researching professional service firms: An introduction and overview. In B. Hinings, et al. (Eds.), The Oxford handbook of professional service firms (pp. 1–26). Oxford: Oxford University Press.
Institute of Medicine (IOM). (2012). Evolution of translational omics: Lessons learned and the path forward. Washington, D.C.: The National Academies Press.
Ioannidis, J. P. A. (2004). Materializing research promisses: Opportunities, priorities and conflicts in translational medicine. Journal of Translational Medicine, 2(1), 5.
Jarvenpaa, S. L., & Majchrzak, A. (2016). Interactive self-regulation theory for sharing and protecting in interorganizational collaborations. Academy of Management Review, 41(1), 9–27.
Jasanoff, S. (2005). Designs on nature: Science and democracy in Europe and the United States. Princeton: Princeton University Press.
Jensen, M. C. (1983). Organization theory and methodology. The Accounting Review, 58(2), 319–339.
Jensen, M. C., & Mechling, W. H. (1976). Theory of firm: Managerial behavior, agency costs and ownership structure. Journal of Financial Economics, 3(4), 305–360.
Jones, C., Hesterly, W. S., & Borgatti, S. P. (1997). A general theory of network governance: Exchange conditions and social mechanisms. Academy of Management Review, 22(4), 911–945.
Kenworthy, N., MacKenzie, R., & Lee, K. (2016). Case studies on corporations and global health governance. London: Rowman & Littlefield International.
King, A. A., & Lenox, M. J. (2017). Industry self-regulation without sanctions: The chemical industry’s responsible care program. Academy of Management Journal, 43(4). https://doi.org/10.5465/1556362.
Klein, H. J. (1989). An integrated control theory model of work motivation. Academy of Management Review, 14(2), 150–172.
Koehn, D. (1994). The ground of professional ethics. London & New York: Routledge.
Krimsky, S. (2007). When conflict-of-interest is a factor in scientific misconduct. Medicine and Law, 26, 447–463.
Kuhn, T. (1962). The structure of scientific revolutions. Chicago: The University of Chicago Press.
Kunneman, H. (2010). Viable alternatives for commercialized science: The case of humanistics. In H. Radder (Ed.), The commodification of academic research: Science and the modern university (pp. 307–336). Pittsburgh: University of Pittsburgh Press.
Links, A. E., Draper D., Lee, E., Guzman, J., Valivullah Z., Maduro, V., … Sincan M. (2016). Distributed cognition and process management enabling individualized translational research: The NIH undiagnosed diseases program experience. Frontiers in Medicine, 3(39). https://doi.org/10.3389/fmed.2016.00039.
Lynn, M. L. (2005). Organizational buffering: Managing boundaries and cores. Organization Studies, 26(1), 37–61.
Merton, R. K. (1942). A note on science and democracy. Journal of Legal and Political Sociology, 1, 115–126.
Millar, C. C. J. M., Peters, K., & Millar, P. H. (2018). Culture, the missing link in value creation and governance in knowledge-intensive institutions? Journal of Public Affairs, 18(1), e1702. https://doi.org/10.1002/pa.1702.
Miller, F. G., & Wertheimer, A. (2011). The fair transaction model of informed consent: An alternative to autonomous authorization. Kennedy Institute of Ethics Journal, 21(3), 201–216.
Mowery, D. C., & Ziedonis, A. A. (2002). Academic patent quality and quantity before and after the Bayh-Dole act in the United States. Research Policy, 31(3), 399–418.
Mukunda, G. (2012). Indispensable: When leaders really matter. Cambridge, MA: Harvard Business School Publishing.
Nielsen, K. L. (Ed.). (2008). Serial analysis of gene expression (SAGE): Methods and protocols. Totowa: Humana Press.
Von Nordenflycht, A. (2010). What is a professional service firm? Towards a theory and taxonomy of knowledge intensive firms. Academy of Management Review, 35(1), 155–174.
Nowotny, H., Scott, P., & Gibbons, M. (2001). Re-thinking science: Knowledge and the public in an age of uncertainty. Oxford: Blackwell.
Okada, E. (2018). Knowledge corruption and governance in academic knowledge-intensive organizations: The case of molecular mutations research. Journal of Public Affairs, 18(1), e1698. https://doi.org/10.1002/pa.1698.
Penrose, E. (1959). The theory of growth of the firm. Oxford: Blackwell.
Pfeffer, J., & Salancik, G. R. (1978). The external control of organizations: A resource dependence perspective. Stanford: Stanford University Press.
Phillips, R. (2003). Stakeholder theory and organizational ethics. San Francisco: Barrett-Koehler Publishers.
Pisano, G. P. (2006). Science business: The promise, the reality, and the future of biotech. Boston: Harvard Business School Press.
Prabowo, S. A., Groschel, M. L., Schmidt, E. D. L., Skrahina, A., Mihaescu, T., & Hastuk, S., et al. (2013). Targeting multidrug-resistant tuberculosis by therapeutic vaccines. Medical Microbiology and Immunology, 302, 95–104.
Radder, H. (Ed.). (2010a). The commodification of academic research: Science and the modern university. Pittsburgh: University of Pittsburgh Press.
Radder, H. (2010b). The commodification of academic research. In H. Radder (Ed.), The commodification of academic research: Science and the modern university (pp. 1–23). Pittsburgh: University of Pittsburgh Press.
Rangan, S., Samii, R., & van Wassenhove, L. K. (2006). Constructive partnerships: When alliances between private firms and public actors can enable creative strategies. Academy of Management Review, 31(3), 738–751.
Rappuoli, R., Blank, S., & Lambert, P. H. (2011). Vaccine discovery and translation of new vaccine technology. Lancet, 378, 360–368.
Rawls, J. (1958/1999). Justice as fairness. In S. Freeman (Ed.), John Rawls: Collected Papers (pp. 47–72). Cambridge, USA: Cambridge University Press.
Reich, M. R. (Ed.). (2002). Public-private partnerships for health. Cambridge: Harvard University Press.
Reiss, J., & Sprenger, J. (2017). Scientific objectivity. In E. N. Zalta (Ed.), The Stanford Encyclopedia of Philosophy (ed.), Summer 2017. Available at https://plato.stanford.edu/archives/sum2017/entries/scientific-objectivity/.
Resnik, D. B. (2008). Scientific autonomy and public oversight. Philosophy of Science, 5(2), 220. https://doi.org/10.3366/e1742360000800336, available as author’s manuscript in PMC2009 Sept 22.
Riordan, M., & Williamson, O. (1985). Asset specificity and economic organization. International Journal of Industrial Organization, 3(4), 365–378.
Rosenau, J., & Czempiel, E. (1992). Governance without government: Order and change in world politics. Cambridge: Cambridge University Press.
Sachs, J. (2001). Thinking boldly. Bulletin of the World Health Organization, 79(8), 772.
Santos, F. M., & Eisenhardt, K. M. (2005). Organizational boundaries and theories of organization. Organization Science, 16(5), 491–508.
Schut, M., von Paassen, A., Leeuwis, C., & Klerlx, L. (2014). Towards dynamic research configurations: A framework for reflection on the contribution of research to policy and innovation processes. Science and Public Policy, 41(2), 207–218.
Sherer, P. D., & Leblebici, H. (2015). Governance in professional service firms. In B. Hinings, D. Muzio, J. Broschak, & L. Empson (Eds.), The Oxford handbook of professional service firms (pp. 189–212). Oxford: Oxford University Press.
Steen, R. G. (2011). Retractions in the medical literature: How many patients are put at risk by flawed research? Journal of Medical Ethics, 37(11), 688–692.
Tamas, B. (2013). The future of drug discovery: Who decides which diseases to treat? London: Academic Press.
Teece, D. J., Pisano, G., & Shuen, A. (1997). Dynamic capabilities and strategic management. Strategic Management Journal, 18(7), 509–533.
Thursby, J. G., & Thursby, M. C. (2011). Has the Bayh-Dole act compromised basic research? Research Policy, 40(8), 1077–1083.
Trispas, M. (2009). Technology, identity, and inertia through the lens of ‘the digital photography company’. Organization Science, 20(2), 441–460.
Truog, R. D. (2017). The United Kingdom sets limits on experimental treatments. JAMA, 318(11). https://doi.org/10.1001/jama.2017.10410.
Velculescu, V. E., Zhang, L., Vogelstein, B., & Kinzler, K. W. (1995). Serial analysis of gene expression. Science, 270(5235), 484–487.
de Vries, M. S. (2013). The challenge of good governance. The Innovation Journal The Public Sector Innovation Journal, 18(1), 1–9.
Weick, K. E. (1995). Sensemaking in organization. Thousand Oaks and London: Sage.
Whitley, R. (2000). The intellectual and social organization of science (2nd ed.). Oxford: Oxford University Press.
Wicks, A. C., Gilbert, D. R., & Freeman, R. E. (1994). A feminist reinterpretation of the stakeholder concept. Business Ethics Quarterly, 4, 475–497.
Williamson, O. E. (1979). Transaction-cost economics: The governance of contractual relations. The Journal of Law and Economics, 22(2), 233–261.
Williamson, O. E. (1981). The economics of organization: The transaction cost approach. American Journal of Sociology, 87(3), 548–577.
Zahra, S. A., Neubaum, D. O., & Hayton, J. C. (2016). Handbook of research on corporate entrepreneurship. Cheltenham and Northampton: Edward Elgar Publishing.
Ziman, J. (2000). Real science. Cambridge: Cambridge University Press.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Copyright information
© 2019 The Author(s)
About this chapter
Cite this chapter
Okada, E. (2019). Introduction. In: Management of Knowledge-Intensive Organizations. Palgrave Macmillan, Cham. https://doi.org/10.1007/978-3-319-97373-9_1
Download citation
DOI: https://doi.org/10.1007/978-3-319-97373-9_1
Published:
Publisher Name: Palgrave Macmillan, Cham
Print ISBN: 978-3-319-97372-2
Online ISBN: 978-3-319-97373-9
eBook Packages: Business and ManagementBusiness and Management (R0)